Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1999-2-19
pubmed:abstractText
-The putative central sympathoinhibitory actions of the dihydropyridine calcium antagonist nifedipine and the effect of dietary sodium on these actions were investigated in spontaneously hypertensive rats (SHR). Regular or high dietary salt was administered from 4 to 8 weeks of age. At 8 weeks, blood pressure (BP), heart rate (HR), and renal sympathetic nerve activity were recorded in conscious rats at rest as well as in response to intravenous (50 microg/kg) and intracerebroventricular (5 and 50 microg/kg) injections of nifedipine and intracerebroventricular injections of vehicle. Resting mean arterial pressure was higher in SHR on high versus regular salt (159+/-3 versus 135+/-4 mm Hg; P<0. 05). Nifedipine administered intracerebroventricularly decreased BP as well as renal sympathetic nerve activity and HR in a dose-related manner. The responses reached their peak at 3 to 5 minutes and lasted approximately 30 minutes. Peak decreases in BP, renal sympathetic nerve activity, and HR in response to both doses of nifedipine were significantly larger in SHR on high versus regular salt. Nifedipine administered intravenously also decreased BP but, in contrast, caused (reflex) increases in renal sympathetic nerve activity and HR. On both diets, intracerebroventricular vehicle did not affect mean arterial pressure, renal sympathetic nerve activity, or HR. These data indicate that in contrast to its peripheral vasodilator effect, centrally administered nifedipine may decrease sympathetic outflow and therefore BP and HR. The enhanced sympathoinhibitory and depressor responses to nifedipine in SHR on high versus regular salt suggest that the sympathetic hyperactivity induced by high salt intake is dependent on neuronal calcium influx via L-type channels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0194-911X
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9931078-Age Factors, pubmed-meshheading:9931078-Animals, pubmed-meshheading:9931078-Blood Pressure, pubmed-meshheading:9931078-Calcium Channel Blockers, pubmed-meshheading:9931078-Cerebral Ventricles, pubmed-meshheading:9931078-Dihydropyridines, pubmed-meshheading:9931078-Heart Rate, pubmed-meshheading:9931078-Injections, Intravenous, pubmed-meshheading:9931078-Kidney, pubmed-meshheading:9931078-Male, pubmed-meshheading:9931078-Nifedipine, pubmed-meshheading:9931078-Pharmaceutical Vehicles, pubmed-meshheading:9931078-Rats, pubmed-meshheading:9931078-Rats, Inbred SHR, pubmed-meshheading:9931078-Rats, Sprague-Dawley, pubmed-meshheading:9931078-Sodium Chloride, Dietary, pubmed-meshheading:9931078-Sympathetic Nervous System, pubmed-meshheading:9931078-Time Factors, pubmed-meshheading:9931078-Vasodilator Agents
pubmed:year
1999
pubmed:articleTitle
Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake.
pubmed:affiliation
Hypertension Unit, University of Ottawa Heart Institute, Ontario, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't